Patrick Finzer

525 total citations
12 papers, 428 citations indexed

About

Patrick Finzer is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Patrick Finzer has authored 12 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Patrick Finzer's work include Cervical Cancer and HPV Research (5 papers), Cancer-related Molecular Pathways (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Patrick Finzer is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Cancer-related Molecular Pathways (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Patrick Finzer collaborates with scholars based in Germany, France and India. Patrick Finzer's co-authors include Frank Rösl, Ubaldo Soto, Harald zur Hausen, Christian Kuntzen, Adriana Aguilar‐Lemarroy, Bhudev C. Das, Michael Stöhr, Claudia Denk, Hajo Delius and Annemarie Poustka and has published in prestigious journals such as Oncogene, International Journal of Cancer and Virology.

In The Last Decade

Patrick Finzer

11 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Finzer Germany 10 233 173 138 99 77 12 428
Ni Sima China 11 259 1.1× 127 0.7× 121 0.9× 82 0.8× 95 1.2× 20 463
Haruka Nishida Japan 12 205 0.9× 82 0.5× 152 1.1× 117 1.2× 128 1.7× 37 472
Julia Bulkescher Germany 10 288 1.2× 106 0.6× 111 0.8× 76 0.8× 134 1.7× 15 427
Robert Valentine United Kingdom 4 210 0.9× 61 0.4× 188 1.4× 80 0.8× 122 1.6× 4 441
Imelda Martínez-Ramírez Mexico 7 180 0.8× 116 0.7× 65 0.5× 40 0.4× 120 1.6× 11 314
Yulan Yan China 15 285 1.2× 83 0.5× 61 0.4× 86 0.9× 167 2.2× 32 468
Marcia M. Clayton United States 12 254 1.1× 376 2.2× 132 1.0× 38 0.4× 148 1.9× 18 658
Yuezhen Xue Singapore 13 220 0.9× 209 1.2× 172 1.2× 79 0.8× 87 1.1× 24 450
Keya Bandyopadhyay United States 12 264 1.1× 71 0.4× 122 0.9× 131 1.3× 20 0.3× 17 492
Sebastian Łukasiak United Kingdom 8 397 1.7× 89 0.5× 111 0.8× 117 1.2× 77 1.0× 9 522

Countries citing papers authored by Patrick Finzer

Since Specialization
Citations

This map shows the geographic impact of Patrick Finzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Finzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Finzer more than expected).

Fields of papers citing papers by Patrick Finzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Finzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Finzer. The network helps show where Patrick Finzer may publish in the future.

Co-authorship network of co-authors of Patrick Finzer

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Finzer. A scholar is included among the top collaborators of Patrick Finzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Finzer. Patrick Finzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Finzer, Patrick. (2017). How we become ill. EMBO Reports. 18(4). 515–518. 9 indexed citations
2.
Finzer, Patrick. (2014). Systemorganisation und Emergenz in der Medizin. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 1 indexed citations
3.
Stöhr, Michael, et al.. (2006). Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells. Cancer Letters. 245(1-2). 103–111. 21 indexed citations
4.
Carrier, Martin & Patrick Finzer. (2006). Explanatory Loops and the Limits of Genetic Reductionism. International Studies in the Philosophy of Science. 20(3). 267–283. 3 indexed citations
5.
Finzer, Patrick, Andreas Krueger, Michael Stöhr, et al.. (2004). HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F–p73 pathway. Oncogene. 23(28). 4807–4817. 34 indexed citations
6.
Finzer, Patrick, et al.. (2003). Phenylbutyrate inhibits growth of cervical carcinoma cells independent of HPV type and copy number. Journal of Cancer Research and Clinical Oncology. 129(2). 107–113. 11 indexed citations
7.
Finzer, Patrick, et al.. (2002). Growth Arrest of HPV-Positive Cells after Histone Deacetylase Inhibition Is Independent of E6/E7 Oncogene Expression. Virology. 304(2). 265–273. 21 indexed citations
8.
Finzer, Patrick, Adriana Aguilar‐Lemarroy, & Frank Rösl. (2002). The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Letters. 188(1-2). 15–24. 77 indexed citations
9.
Finzer, Patrick, Christian Kuntzen, Ubaldo Soto, Harald zur Hausen, & Frank Rösl. (2001). Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene. 20(35). 4768–4776. 97 indexed citations
10.
Soto, Ubaldo, et al.. (2000). Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition. International Journal of Cancer. 86(6). 811–817. 38 indexed citations
11.
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ni Sima Breakdown of academic impact, for papers by Haruka Nishida Breakdown of academic impact, for papers by Julia Bulkescher Breakdown of academic impact, for papers by Robert Valentine Breakdown of academic impact, for papers by Imelda Martínez-Ramírez Breakdown of academic impact, for papers by Yulan Yan Breakdown of academic impact, for papers by Marcia M. Clayton Breakdown of academic impact, for papers by Yuezhen Xue Breakdown of academic impact, for papers by Keya Bandyopadhyay Breakdown of academic impact, for papers by Sebastian Łukasiak
Rankless by CCL
2026